Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
申请人:AbbVie Inc.
公开号:US08889675B2
公开(公告)日:2014-11-18
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein.
本发明揭示了一种抑制抗凋亡Bcl-xL蛋白活性的化合物,包含该化合物的组合物和治疗表达抗凋亡Bcl-xL蛋白的疾病的方法。